Brown Advisory Inc Graybug Vision, Inc. Transaction History

Brown Advisory Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.46 - $1.05 $3,434 - $7,840	-7,467 Reduced 40.73%	10,866 $5,000
Q3 2022 Nov 14, 2022	BUY	$0.93 - $1.18 $1,146 - $1,454	1,233 Added 7.21%	18,333 $17,000
Q2 2022 Nov 14, 2022	SELL	$0.76 - $1.25 $2,280 - $3,750	-3,000 Reduced 14.93%	17,100 $18,000
Q2 2022 Aug 02, 2022	SELL	$0.76 - $1.25 $2,280 - $3,750	-3,000 Reduced 15.9%	15,867 $17,000
Q1 2022 Nov 14, 2022	BUY	$1.13 - $1.93 $4,783 - $8,169	4,233 Added 26.68%	20,100 $25,000
Q1 2022 May 09, 2022	BUY	$1.13 - $1.93 $5,649 - $9,650	5,000 Added 36.06%	18,867 $23,000
Q3 2021 Nov 12, 2021	SELL	$3.18 - $5.17 $7,841 - $12,749	-2,466 Reduced 15.1%	13,867 $46,000
Q2 2021 Jul 29, 2021	SELL	$3.53 - $6.1 $40,474 - $69,942	-11,466 Reduced 41.25%	16,333 $88,000
Q1 2021 May 14, 2021	BUY	$5.55 - $35.0 $154,284 - $972,965	27,799 New	27,799 $154,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.